Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Gritstone Oncology

Gritstone Oncology?uq=UG6efJS6
2015 FOUNDED
PUBLIC STATUS
91-100 EMPLOYEES
GRTS STOCK SYMBOL
$15.01 SHARE PRICE (As of Friday Closing)
Description

Operator of an immuno-oncology platform designed to develop next-generation personalized cancer therapeutics. The company's immuno-oncology platform develops personalized cancer therapy by exploiting the inherent vulnerability of cancer tumor cells as well as identifying patient's unique set of tumor antigens thereby using them in a therapeutic immunization strategy, enabling patients to recover faster from cancer.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Stock Exchange
NAS
Primary Office
  • 5858 Horton Street
  • Suite 210
  • Emeryville, CA 94608
  • United States

+1 (510) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Gritstone Oncology’s full profile, request a free trial.

Gritstone Oncology Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$11.61 - $15.49 $447M $15.49 255K 28.8M

Gritstone Oncology Financials Summary

In Thousands,
USD
TTM
30-Jun-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
EBITDA (53,004) (39,793) (18,157)
Net Income (55,668) (41,377) (18,750)
Total Assets 95,951 117,300 46,421
Total Debt 10,508 10,521 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Gritstone Oncology Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Gritstone Oncology‘s full profile, request access.

Request full access to PitchBook

Gritstone Oncology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is reserved for PitchBook Platform users. To explore Gritstone Oncology‘s full profile, request access.

Request full access to PitchBook
To view this company’s complete Cap Table, request access »

Gritstone Oncology Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Gritstone Oncology‘s full profile, request access.

Request full access to PitchBook

Gritstone Oncology Executive Team (14)

Name Title Board
Seat
Contact
Info
Andrew Allen MD Co-Founder, President, Chief Executive Officer & Board Member
Jean-Marc Bellemin Chief Financial Officer & Executive Vice President, Finance
Roman Yelensky Ph.D Chief Technology Officer & Executive Vice President
Karin Jooss Ph.D Executive Vice President, Research & Chief Scientific Officer
Matthew Hawryluk Ph.D Executive Vice President & Chief Business Officer
You’re viewing 5 of 14 executives. Get the full list »

Gritstone Oncology Board Members (8)

Name Representing Role Since Contact
Info
Andrew Allen MD Gritstone Oncology Co-Founder, President, Chief Executive Officer & Board Member 000 0000
Judith Li Lilly Asia Ventures Board Member 000 0000
Nicholas Simon Clarus Ventures Board Member 000 0000
Patrick Mahaffy Self Chairman 000 0000
Peter Svennilson The Column Group Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »